Avidity Biosciences, Inc.
RNA
$71.46
-$0.12-0.17%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.88B | 1.18B | 1.38B | 1.50B | 1.59B |
| Total Receivables | 15.04M | 8.54M | 36.58M | 28.22M | 19.21M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 15.15M | 15.98M | 18.52M | 12.57M | 14.06M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 59.99M | 42.90M | -- | -- | -- |
| Total Current Assets | 1.97B | 1.25B | 1.43B | 1.54B | 1.62B |
|
|
|||||
| Total Current Assets | 1.97B | 1.25B | 1.43B | 1.54B | 1.62B |
| Net Property, Plant & Equipment | 74.35M | 24.76M | 20.57M | 18.29M | 15.79M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 93.84M | 93.60M | 3.53M | 3.32M | 3.11M |
| Total Assets | 2.13B | 1.37B | 1.46B | 1.56B | 1.64B |
|
|
|||||
| Total Accounts Payable | 9.63M | 3.91M | 6.63M | 8.46M | 7.66M |
| Total Accrued Expenses | 137.16M | 113.69M | 60.37M | 64.73M | 60.21M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.97M | 3.93M | 3.88M | 3.84M | 3.80M |
| Total Finance Division Other Current Liabilities | 19.12M | 13.54M | 13.98M | 20.99M | 19.66M |
| Total Other Current Liabilities | 19.12M | 13.54M | 13.98M | 20.99M | 19.66M |
| Total Current Liabilities | 169.88M | 135.06M | 84.87M | 98.02M | 91.33M |
|
|
|||||
| Total Current Liabilities | 169.88M | 135.06M | 84.87M | 98.02M | 91.33M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 46.00M | 1.21M | 2.09M | 2.96M | 3.80M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 32.07M | 39.99M | 43.40M | 37.96M | 42.26M |
| Total Liabilities | 247.94M | 176.26M | 130.35M | 138.94M | 137.39M |
|
|
|||||
| Common Stock & APIC | 3.23B | 2.36B | 2.33B | 2.32B | 2.29B |
| Retained Earnings | -1.34B | -1.17B | -1.01B | -893.07M | -790.81M |
| Treasury Stock & Other | 1.77M | 1.78M | 2.77M | 2.90M | 7.10M |
| Total Common Equity | 1.89B | 1.19B | 1.33B | 1.42B | 1.50B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1.89B | 1.19B | 1.33B | 1.42B | 1.50B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1.89B | 1.19B | 1.33B | 1.42B | 1.50B |
|
|
|||||